Voluntary Faculty are clinicians or other professionals who contribute significantly to Yale School of Medicine's educational programs but are not employed by the school.
Voluntary rank detailsVinita Parkash, MBBS, MPH
Associate Clinical ProfessorAbout
Copy Link
Titles
Affiliated Faculty, Yale Institute for Global Health
Biography
Vinita Parkash is a Gynecological Pathologist and a Quality and Safety expert. She received her pathology training at YaleSchool of Medicine and at Memorial Sloan Kettering Cancer Center. Since then, she has served as the founding two-term co-chair of the education committee for the International Society of Gynecological Pathology, whence she led the first-ever effort to produce good practice statements/guidelines for gynecological cancers. Dr. Parkash has promoted improved gynecological pathology diagnosis in low resource settings in Asia and Africa and is a mentor in the virtual gynecological pathology fellowship pilot for the International Gynecological Cancer Society. Her work on promoting cervical cancer screening in low resource settings in India has received several awards from the American Society of Cytopathology. In the advent of the Dobbs v Jackson decision, Dr. Parkash led the effort to develop guidelines for abortion tissue processing for the College of American Pathologists, for which she received the President’s Honors award. She launched and continues to moderate the Gynecological Pathology listserv, is a contributor to the 4th and 5th editions of the WHO-blue book on Tumors of the Female Genital Tract, the co-editor of a book on endometrial biopsies, and serves on several editorial boards.
Dr. Parkash completed her MPH in health policy from the Yale School of Public Health and a fellowship in diagnostic error reduction from the Society for the Improvement of Diagnosis in Medicine. She is the former director of quality and safety for the Yale Department of Pathology. She has designed and taught courses on quality and safety in healthcare for national meetings, the Yale School of Public Health, and Quinnipiac University, among others. She is a member of several expert panels on diagnostic error reduction including for AHRQ, Leapfrog, and the College of American Pathologists. Dr. Parkashis also a member of the ACGME’s Program Directors in Patient Safety and Quality (PDPQ) Educators Network, an effort directed at strengthening training in quality and safety for trainees.
Dr. Parkash’s current research focuses on reducing diagnostic error by improving patient engagement in the test management cycle, and on improving trust and engagement of patients in healthcare, efforts in which she collaborates with researchers at Yale School of Public Health and the Betsy Lehman Center for patient safety.
Appointments
Health Policy & Management
Senior Research ScientistPrimary
Other Departments & Organizations
Education & Training
- MPH
- Yale School of Public Health, Health Policy and Management (2019)
- Fellow
- Memorial Sloan Kettering Cancer Center (1994)
- Resident
- Yale-New Haven Hospital (1993)
- Resident
- Hospital of St. Raphael (1992)
- MBBS
- Lady Hardinge Medical College (1989)
Research
Copy Link
Overview
Public Health Interests
ORCID
0000-0002-8880-9108
Research at a Glance
Yale Co-Authors
Publications Timeline
Mark Schlesinger, PhD
Sudhir Perincheri, PhD, MBBS
Publications
2025
International medical graduates amongst pathology leadership roles: more than meets the eye
Smith S, Parkash V. International medical graduates amongst pathology leadership roles: more than meets the eye. Academic Pathology 2025, 12: 100207. PMID: 40761682, PMCID: PMC12320155, DOI: 10.1016/j.acpath.2025.100207.Peer-Reviewed Original ResearchEditorial Comment on Mucinous Neoplasms Associated with Mature Cystic Teratomas: A Clinicopathologic Study of 50 Cases: Are We Ready for Nomenclature Change?
Parkash V. Editorial Comment on Mucinous Neoplasms Associated with Mature Cystic Teratomas: A Clinicopathologic Study of 50 Cases: Are We Ready for Nomenclature Change? Annals Of Diagnostic Pathology 2025, 78: 152514. PMID: 40461394, DOI: 10.1016/j.anndiagpath.2025.152514.Peer-Reviewed Original ResearchPilomatrix-like High-grade Endometrial Carcinoma
Zhou F, Qin L, Huang S, Lin W, Zhang H, Parkash V, Zheng W. Pilomatrix-like High-grade Endometrial Carcinoma. The American Journal Of Surgical Pathology 2025, 49: 818-829. PMID: 40202384, DOI: 10.1097/pas.0000000000002402.Peer-Reviewed Original ResearchCitationsConceptsHigh-grade endometrial carcinomasEndometrial carcinomaShadow cellsResponse to immune checkpoint inhibitorsCTNNB1 exon 3 mutationsLow-level HER2 expressionHigh-grade endometrial cancerImmune checkpoint inhibitorsPD-L1 expressionHER2-Targeted TherapyHigh-grade malignancyExon 3 mutationsLow-grade endometrioidBasaloid tumor cellsSquamous cell carcinomaAggressive endometrial carcinomasHigh-grade endometrioidFolate receptor alphaAggressive clinicopathological featuresComedo-type necrosisMolecular featuresBasaloid componentCheckpoint inhibitorsPR negativityPD-L1
2024
Development of an FRα Companion Diagnostic Immunohistochemical Assay for Mirvetuximab Soravtansine.
Parkash V, Smith S. Development of an FRα Companion Diagnostic Immunohistochemical Assay for Mirvetuximab Soravtansine. Archives Of Pathology & Laboratory Medicine 2024, 149: 207-208. PMID: 39734248, DOI: 10.5858/arpa.2024-0277-le.Peer-Reviewed Original ResearchCitationsAssessing the impact of deep‐learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes
Bogaerts J, Steenbeek M, Bokhorst J, van Bommel M, Abete L, Addante F, Brinkhuis M, Chrzan A, Cordier F, Devouassoux‐Shisheboran M, Fernández‐Pérez J, Fischer A, Gilks C, Guerriero A, Jaconi M, Kleijn T, Kooreman L, Martin S, Milla J, Narducci N, Ntala C, Parkash V, de Pauw C, Rabban J, Rijstenberg L, Rottscholl R, Staebler A, Van de Vijver K, Zannoni G, van Zanten M, Bart J, Bentz J, Bosse T, Bulten J, Desouki M, Lastra R, Numan T, Schoolmeester J, Schwartz L, Shih I, Soong T, Turashvili G, Vang R, Volchek M, Aliredjo R, Kusters‐Vandevelde H, de Hullu J, Simons M, van der Laak J. Assessing the impact of deep‐learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes. The Journal Of Pathology Clinical Research 2024, 10: e70006. PMID: 39439213, PMCID: PMC11496567, DOI: 10.1002/2056-4538.70006.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsDeep learning modelsSerous tubal intraepithelial carcinomaArtificial intelligenceAI assistanceDiagnosis of serous tubal intraepithelial carcinomaTubal intraepithelial carcinomaReview timeFallopian tubeIntraepithelial carcinomaAI supportHigh-grade serous ovarian carcinomaSerous ovarian carcinomaStandalone performanceAverage sensitivityGroup of pathologistsAccuracyOvarian carcinomaHistopathological diagnosisPathologist performanceMixed-model analysisDiagnostic certaintyCarcinomaDiagnostic settingAdverse events and perceived abandonment: learning from patients’ accounts of medical mishaps
Schlesinger M, Dhingra I, Fain B, Prentice J, Parkash V. Adverse events and perceived abandonment: learning from patients’ accounts of medical mishaps. BMJ Open Quality 2024, 13: e002848. PMID: 39147403, PMCID: PMC11331972, DOI: 10.1136/bmjoq-2024-002848.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsAdverse medical eventsMedical mishapsMedical eventsPerceived abandonmentEnhance patient engagementMixed-methods analysis of responsesPatient safety concernsFeelings of abandonmentOpen-ended responsesCare partnersMedication errorsPatient engagementImpact of adverse eventsMixed-methods analysisPatient accountsVulnerable populationsAdverse eventsUnder-reportingAnalysis of responsesProvidersTherapeutic allianceAttitudinal changeCoding schemaCliniciansRespondentsVirtual Remote Pathology Education in Support of Virtual Remote Gynecologic-Oncology Training.
Hassell L, Wong A, Parkash V, Ng J, Tran N, Huynh L, Han T, Quynh T, Ngoc P, Quy T. Virtual Remote Pathology Education in Support of Virtual Remote Gynecologic-Oncology Training. Archives Of Pathology & Laboratory Medicine 2024, 149: 597-601. PMID: 38802102, DOI: 10.5858/arpa.2023-0449-ep.Peer-Reviewed Original ResearchCitationsConceptsInternational Gynecologic Cancer SocietyTumor boardAccuracy of pathological diagnosisMentoring sessionsIncreased confidenceGYN ONCsPathological diagnosisCancer SocietyMonths of studySubspecialty workforceObservations of cliniciansAssessment of qualityDiagnostic scoreModern therapyPracticing pathologistsPathology workforceEducational effortsCase sharingParticipating pathologistsPathology supportSubspecialtyCollaborative modelPilot projectPathological issuesMonthsEndometriosis in a 22-Year-Old with Premature Ovarian Insufficiency Secondary to Pre-Pubertal Bone Marrow Transplant: a Case Report
Liao C, Ramani S, Parkash V, Kodaman P. Endometriosis in a 22-Year-Old with Premature Ovarian Insufficiency Secondary to Pre-Pubertal Bone Marrow Transplant: a Case Report. Reproductive Sciences 2024, 31: 2700-2705. PMID: 38806998, DOI: 10.1007/s43032-024-01601-z.Peer-Reviewed Original ResearchConceptsPremature ovarian insufficiencyBone marrow transplantationProgressive dysmenorrheaPelvic painMarrow transplantationContraceptive pillsInherited bone marrow failure syndromeBone marrow failure syndromesSuperficial endometriotic lesionsChronic pelvic painMarrow failure syndromesOral contraceptive pillsCases of endometriosisDiamond-Blackfan anemiaReproductive age womenSpontaneous ovarian activityCyclic progestinNulligravid femaleWorsening arthralgiasTransdermal estrogenDiagnostic laparoscopyGonadotoxic chemotherapyOral estradiolHormone therapyOvarian insufficiencyThe Malignant Potential of Ovarian Steroid Cell Tumors Revisited
Fadare O, Fard E, Bhargava R, Desouki M, Hanley K, Ip P, Li J, Lu B, Medeiros F, Ng J, Parkash V, Pinto A, Quick C, Skala S, Tokuyama M, Turashvili G, Wei C, Xing D, Zheng W, Soong T, Howitt B. The Malignant Potential of Ovarian Steroid Cell Tumors Revisited. The American Journal Of Surgical Pathology 2024, 48: 570-580. PMID: 38512100, DOI: 10.1097/pas.0000000000002201.Peer-Reviewed Original ResearchCitationsConceptsSteroid cell tumorPredictor of patient outcomeDied of diseaseTumor hemorrhageTumor necrosisClinicopathological predictorsTumor sizeMalignant potentialCell tumorsAssociated with reduced recurrence-free survivalCases of steroid cell tumoursOvarian steroid cell tumorTumor size >4Median tumor sizeMicroscopic tumour necrosisMedian patient agePredictors of recurrenceRecurrence-free survivalMulti-institutional cohortPatient outcomesStage IA casesAssociated with recurrenceHigh-power fieldsLog-rank testUnivariate Cox model
2023
Recent Advances in Genitourinary Tumors: Updates From the 5th Edition of the World Health Organization Blue Book Series.
Riddle N, Parkash V, Guo C, Shen S, Perincheri S, Ramirez A, Auerbach A, Belchis D, Humphrey P. Recent Advances in Genitourinary Tumors: Updates From the 5th Edition of the World Health Organization Blue Book Series. Archives Of Pathology & Laboratory Medicine 2023, 148: 952-964. PMID: 38031818, DOI: 10.5858/arpa.2022-0509-ra.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricConceptsMale genital tumorsWorld Health Organization classificationGenital tumorsOrganization classificationClinical practiceDate clinical practiceRoutine clinical practiceWorld Health OrganizationUrinary tumorsGenitourinary tumorsSimilar tumorsDiagnostic criteriaTumor seriesTumorsGenetic syndromesOrgan systemsHealth OrganizationComprehensive updateUrinaryNew entitySyndromeGenomic terminology
Academic Achievements & Community Involvement
Copy Link
Honors
honor 2024 CAP Distinguished Patient Care Award
11/01/2024National AwardCollege of American Pathologistshonor NAM Scholars in Diagnostic Excellence
05/25/2023National AwardNational Academy of Medicine
News
Copy Link
Get In Touch
Copy Link